Live Quote · NASDAQCVKDHealthcare· Biotechnology

Cadrenal Therapeutics, Inc. Common Stock

$1.70▲ 0.59%(+$0.01)
MKT CAP $7.01MNEXT EARNINGS Mar 30, 2027
50%
Bullish
TickerSpark Score
58/100
▌ Mixed
80
Valuation
20
Profitability
55
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CVKD research report →

Analyst Price Target
$32.00+1782.4% vs. today

Range $32 – $32

Analyst RatingBuy
1 Buy0 Hold0 Sell

Price Chart

-84.96% · this period
$12.29$6.58$0.87Nov 20May 26Nov 20
52-Week Range8% of range
Low
$0.82
Current
$1.70
High
$12.50